Hematox vs SOHO365

Hematox®, a bibliographical databank based on drug-induced blood disorders, was created in 1983 by Michel BIOUR (MD, PhD), and monthly updated in accordance with other bibliographical databases to the analysis of the references cited in the articles. All the published cases for selection and classification were re-evaluated in accordance with criterions usually validated in hematology. 1069 drugs are registered with 15126 corresponding and available references. Anticancer drugs and immunomodulators, well known for their intrinsic hematotoxicity, are not indexed in Hematox.

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders. Since that time, approximately 8,000 members from 110 countries have joined the society from around the globe. SOHO is a global society designed specifically for clinicians, research scientists and related health care professionals who specialize in the research and treatment of patients with hematologic malignancies. SOHO’s mission is to expedite worldwide research and education through the exchange of scientific information. Organized by its founders and world class committees, SOHO is the only society specific to this field. SOHO represents physicians and other professionals from all corners of the world. SOHO is leading vital efforts to further treatments for those with hematologic malignancies. Become a SOHO Member free-of-charge. Join us and experience the benefits of membership at http://sohoonline.org ! Mobile app features: • Instant connections to our SOHO Community of nearly 8,000 members • Access to a comprehensive Resource Center that includes slides, publications, abstracts, videos and more • Connection to our SOHO DocMatter Community for hematologic oncology discussions, questions and education • Access to our official journal, ‘Clinical Lymphoma Myeloma and Leukemia’and our news publication, 'Blood Cancers Today' • Direct access to event information and registration with significant member-only discounts • Set SOHO reminders and receive alerts within the App • Connect to the App through Facebook, LinkedIn, and Twitter